Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Alzheimer's Disease

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 257 articles:
HTML format
Text format



Single Articles


    January 2017
  1. GAVIDIA-BOVADILLA G, Kanaan-Izquierdo S, Mataro-Serrat M, Perera-Lluna A, et al
    Early Prediction of Alzheimer's Disease Using Null Longitudinal Model-Based Classifiers.
    PLoS One. 2017;12:e0168011.
    PubMed     Text format     Abstract available


  2. PAPAZOGLOU A, Soos J, Lundt A, Wormuth C, et al
    Motor Cortex Theta and Gamma Architecture in Young Adult APPswePS1dE9 Alzheimer Mice.
    PLoS One. 2017;12:e0169654.
    PubMed     Text format     Abstract available


  3. SONG Y, Kim HD, Lee MK, Hong IH, et al
    Maysin and Its Flavonoid Derivative from Centipedegrass Attenuates Amyloid Plaques by Inducting Humoral Immune Response with Th2 Skewed Cytokine Response in the Tg (APPswe, PS1dE9) Alzheimer's Mouse Model.
    PLoS One. 2017;12:e0169509.
    PubMed     Text format     Abstract available


  4. LI Y, Li Y, Li X, Zhang S, et al
    Head Injury as a Risk Factor for Dementia and Alzheimer's Disease: A Systematic Review and Meta-Analysis of 32 Observational Studies.
    PLoS One. 2017;12:e0169650.
    PubMed     Text format     Abstract available


  5. PAN X, Sang S, Fei G, Jin L, et al
    Enhanced Activities of Blood Thiamine Diphosphatase and Monophosphatase in Alzheimer's Disease.
    PLoS One. 2017;12:e0167273.
    PubMed     Text format     Abstract available


  6. MELLOTT TJ, Huleatt OM, Shade BN, Pender SM, et al
    Perinatal Choline Supplementation Reduces Amyloidosis and Increases Choline Acetyltransferase Expression in the Hippocampus of the APPswePS1dE9 Alzheimer's Disease Model Mice.
    PLoS One. 2017;12:e0170450.
    PubMed     Text format     Abstract available


  7. CAI K, Xu H, Guan H, Zhu W, et al
    Identification of Early-Stage Alzheimer's Disease Using Sulcal Morphology and Other Common Neuroimaging Indices.
    PLoS One. 2017;12:e0170875.
    PubMed     Text format     Abstract available


  8. KASTANENKA KV, Hou SS, Shakerdge N, Logan R, et al
    Optogenetic Restoration of Disrupted Slow Oscillations Halts Amyloid Deposition and Restores Calcium Homeostasis in an Animal Model of Alzheimer's Disease.
    PLoS One. 2017;12:e0170275.
    PubMed     Text format     Abstract available


  9. MORIMOTO S, Takao M, Hatsuta H, Nishina Y, et al
    Homovanillic acid and 5-hydroxyindole acetic acid as biomarkers for dementia with Lewy bodies and coincident Alzheimer's disease: An autopsy-confirmed study.
    PLoS One. 2017;12:e0171524.
    PubMed     Text format     Abstract available


  10. MIN LJ, Kobayashi Y, Mogi M, Tsukuda K, et al
    Administration of bovine casein-derived peptide prevents cognitive decline in Alzheimer disease model mice.
    PLoS One. 2017;12:e0171515.
    PubMed     Text format     Abstract available


  11. COVA I, Pomati S, Maggiore L, Forcella M, et al
    Nutritional status and body composition by bioelectrical impedance vector analysis: A cross sectional study in mild cognitive impairment and Alzheimer's disease.
    PLoS One. 2017;12:e0171331.
    PubMed     Text format     Abstract available


  12. MORRIS JK, Vidoni ED, Johnson DK, Van Sciver A, et al
    Aerobic exercise for Alzheimer's disease: A randomized controlled pilot trial.
    PLoS One. 2017;12:e0170547.
    PubMed     Text format     Abstract available


  13. XU W, Liu J, Ma D, Yuan G, et al
    Capsaicin reduces Alzheimer-associated tau changes in the hippocampus of type 2 diabetes rats.
    PLoS One. 2017;12:e0172477.
    PubMed     Text format     Abstract available


  14. SCHMIDT SA, Ording AG, Horvath-Puho E, Sorensen HT, et al
    Non-melanoma skin cancer and risk of Alzheimer's disease and all-cause dementia.
    PLoS One. 2017;12:e0171527.
    PubMed     Text format     Abstract available


  15. OGAMA N, Sakurai T, Nakai T, Niida S, et al
    Impact of frontal white matter hyperintensity on instrumental activities of daily living in elderly women with Alzheimer disease and amnestic mild cognitive impairment.
    PLoS One. 2017;12:e0172484.
    PubMed     Text format     Abstract available


  16. JI H, Wang Y, Liu G, Chang L, et al
    Elevated OPRD1 promoter methylation in Alzheimer's disease patients.
    PLoS One. 2017;12:e0172335.
    PubMed     Text format     Abstract available


  17. TOLPPANEN AM, Voutilainen A, Taipale H, Tanskanen A, et al
    Regional changes in psychotropic use among Finnish persons with newly diagnosed Alzheimer's disease in 2005-2011.
    PLoS One. 2017;12:e0173450.
    PubMed     Text format     Abstract available


  18. LONG X, Chen L, Jiang C, Zhang L, et al
    Prediction and classification of Alzheimer disease based on quantification of MRI deformation.
    PLoS One. 2017;12:e0173372.
    PubMed     Text format     Abstract available


  19. HOY AR, Ly M, Carlsson CM, Okonkwo OC, et al
    Microstructural white matter alterations in preclinical Alzheimer's disease detected using free water elimination diffusion tensor imaging.
    PLoS One. 2017;12:e0173982.
    PubMed     Text format     Abstract available


  20. MELLOTT TJ, Huleatt OM, Shade BN, Pender SM, et al
    Correction: Perinatal Choline Supplementation Reduces Amyloidosis and Increases Choline Acetyltransferase Expression in the Hippocampus of the APPswePS1dE9 Alzheimer's Disease Model Mice.
    PLoS One. 2017;12:e0174875.
    PubMed     Text format     Abstract available


  21. SON SJ, Kim J, Park H
    Structural and functional connectional fingerprints in mild cognitive impairment and Alzheimer's disease patients.
    PLoS One. 2017;12:e0173426.
    PubMed     Text format     Abstract available


  22. LIN TW, Chang CF, Chang YJ, Liao YH, et al
    Alzheimer's amyloid-beta A2T variant and its N-terminal peptides inhibit amyloid-beta fibrillization and rescue the induced cytotoxicity.
    PLoS One. 2017;12:e0174561.
    PubMed     Text format     Abstract available


  23. TU MC, Lo CP, Huang CF, Hsu YH, et al
    Effectiveness of diffusion tensor imaging in differentiating early-stage subcortical ischemic vascular disease, Alzheimer's disease and normal ageing.
    PLoS One. 2017;12:e0175143.
    PubMed     Text format     Abstract available


  24. VAN GIJSEL-BONNELLO M, Baranger K, Benech P, Rivera S, et al
    Metabolic changes and inflammation in cultured astrocytes from the 5xFAD mouse model of Alzheimer's disease: Alleviation by pantethine.
    PLoS One. 2017;12:e0175369.
    PubMed     Text format     Abstract available


  25. KASAI T, Kondo M, Ishii R, Tanaka A, et al
    Abeta levels in the jugular vein and high molecular weight Abeta oligomer levels in CSF can be used as biomarkers to indicate the anti-amyloid effect of IVIg for Alzheimer's disease.
    PLoS One. 2017;12:e0174630.
    PubMed     Text format     Abstract available


  26. YOSHINAGA T, Nishimata H, Kajiya Y, Yokoyama S, et al
    Combined assessment of serum folate and hemoglobin as biomarkers of brain amyloid beta accumulation.
    PLoS One. 2017;12:e0175854.
    PubMed     Text format     Abstract available


  27. HAAKSMA ML, Vilela LR, Marengoni A, Calderon-Larranaga A, et al
    Comorbidity and progression of late onset Alzheimer's disease: A systematic review.
    PLoS One. 2017;12:e0177044.
    PubMed     Text format     Abstract available


  28. VALLEJO V, Wyss P, Rampa L, Mitache AV, et al
    Evaluation of a novel Serious Game based assessment tool for patients with Alzheimer's disease.
    PLoS One. 2017;12:e0175999.
    PubMed     Text format     Abstract available


  29. TASCONE LDS, Payne ME, MacFall J, Azevedo D, et al
    Cortical brain volume abnormalities associated with few or multiple neuropsychiatric symptoms in Alzheimer's disease.
    PLoS One. 2017;12:e0177169.
    PubMed     Text format     Abstract available


  30. FANG J, Wang L, Li Y, Lian W, et al
    AlzhCPI: A knowledge base for predicting chemical-protein interactions towards Alzheimer's disease.
    PLoS One. 2017;12:e0178347.
    PubMed     Text format     Abstract available


  31. LV F, Yang X, Cui C, Su C, et al
    Exogenous expression of Drp1 plays neuroprotective roles in the Alzheimer's disease in the Abeta42 transgenic Drosophila model.
    PLoS One. 2017;12:e0176183.
    PubMed     Text format     Abstract available


  32. CHRISTENSEN A, Pike CJ
    Age-dependent regulation of obesity and Alzheimer-related outcomes by hormone therapy in female 3xTg-AD mice.
    PLoS One. 2017;12:e0178490.
    PubMed     Text format     Abstract available


  33. LEE SE, Hyun H, Park MR, Choi Y, et al
    Production of transgenic pig as an Alzheimer's disease model using a multi-cistronic vector system.
    PLoS One. 2017;12:e0177933.
    PubMed     Text format     Abstract available


  34. KAZEMIFAR S, Manning KY, Rajakumar N, Gomez FA, et al
    Spontaneous low frequency BOLD signal variations from resting-state fMRI are decreased in Alzheimer disease.
    PLoS One. 2017;12:e0178529.
    PubMed     Text format     Abstract available


  35. CHIU PY, Wang CW, Tsai CT, Li SH, et al
    Depression in dementia with Lewy bodies: A comparison with Alzheimer's disease.
    PLoS One. 2017;12:e0179399.
    PubMed     Text format     Abstract available


  36. NEWMAN M, Halter L, Lim A, Lardelli M, et al
    Mitochondrion to endoplasmic reticulum apposition length in zebrafish embryo spinal progenitors is unchanged in response to perturbations associated with Alzheimer's disease.
    PLoS One. 2017;12:e0179859.
    PubMed     Text format     Abstract available


  37. BOWLES EJA, Walker RL, Anderson ML, Dublin S, et al
    Risk of Alzheimer's disease or dementia following a cancer diagnosis.
    PLoS One. 2017;12:e0179857.
    PubMed     Text format     Abstract available


  38. FANIA C, Arosio B, Capitanio D, Torretta E, et al
    Protein signature in cerebrospinal fluid and serum of Alzheimer's disease patients: The case of apolipoprotein A-1 proteoforms.
    PLoS One. 2017;12:e0179280.
    PubMed     Text format     Abstract available


  39. XING HY, Li B, Peng D, Wang CY, et al
    A novel monoclonal antibody against the N-terminus of Abeta1-42 reduces plaques and improves cognition in a mouse model of Alzheimer's disease.
    PLoS One. 2017;12:e0180076.
    PubMed     Text format     Abstract available


  40. MODI KK, Jana A, Ghosh S, Watson R, et al
    Correction: A Physically-Modified Saline Suppresses Neuronal Apoptosis, Attenuates Tau Phosphorylation and Protects Memory in an Animal Model of Alzheimer's Disease.
    PLoS One. 2017;12:e0180602.
    PubMed     Text format     Abstract available


  41. HAN Z, Huang H, Gao Y, Huang Q, et al
    Functional annotation of Alzheimer's disease associated loci revealed by GWASs.
    PLoS One. 2017;12:e0179677.
    PubMed     Text format     Abstract available


  42. YU L, Lutz MW, Wilson RS, Burns DK, et al
    APOE epsilon4-TOMM40 '523 haplotypes and the risk of Alzheimer's disease in older Caucasian and African Americans.
    PLoS One. 2017;12:e0180356.
    PubMed     Text format     Abstract available


  43. MASTROENI D, Sekar S, Nolz J, Delvaux E, et al
    ANK1 is up-regulated in laser captured microglia in Alzheimer's brain; the importance of addressing cellular heterogeneity.
    PLoS One. 2017;12:e0177814.
    PubMed     Text format     Abstract available


  44. KONG W, Mou X, Deng J, Di B, et al
    Differences of immune disorders between Alzheimer's disease and breast cancer based on transcriptional regulation.
    PLoS One. 2017;12:e0180337.
    PubMed     Text format     Abstract available


  45. GUAN C, Dang R, Cui Y, Liu L, et al
    Characterization of plasma metal profiles in Alzheimer's disease using multivariate statistical analysis.
    PLoS One. 2017;12:e0178271.
    PubMed     Text format     Abstract available


  46. ITOH Y, Voskuhl RR
    Cell specificity dictates similarities in gene expression in multiple sclerosis, Parkinson's disease, and Alzheimer's disease.
    PLoS One. 2017;12:e0181349.
    PubMed     Text format     Abstract available


  47. ZHANG C, Rissman RA
    Corticotropin-releasing factor receptor-1 modulates biomarkers of DNA oxidation in Alzheimer's disease mice.
    PLoS One. 2017;12:e0181367.
    PubMed     Text format     Abstract available


  48. LLANO DA, Bundela S, Mudar RA, Devanarayan V, et al
    A multivariate predictive modeling approach reveals a novel CSF peptide signature for both Alzheimer's Disease state classification and for predicting future disease progression.
    PLoS One. 2017;12:e0182098.
    PubMed     Text format     Abstract available


  49. DROLLE E, Negoda A, Hammond K, Pavlov E, et al
    Changes in lipid membranes may trigger amyloid toxicity in Alzheimer's disease.
    PLoS One. 2017;12:e0182194.
    PubMed     Text format     Abstract available


  50. YASAR S, Jusue-Torres I, Lu J, Robison J, et al
    Alzheimer's disease pathology and shunt surgery outcome in normal pressure hydrocephalus.
    PLoS One. 2017;12:e0182288.
    PubMed     Text format     Abstract available


  51. PARK KW, Kim EJ, Han HJ, Shim YS, et al
    Efficacy and tolerability of rivastigmine patch therapy in patients with mild-to-moderate Alzheimer's dementia associated with minimal and moderate ischemic white matter hyperintensities: A multicenter prospective open-label clinical trial.
    PLoS One. 2017;12:e0182123.
    PubMed     Text format     Abstract available


  52. FRUZANGOHAR M, Ebrahimie E, Adelson DL
    A novel hypothesis-unbiased method for Gene Ontology enrichment based on transcriptome data.
    PLoS One. 2017;12:e0170486.
    PubMed     Text format     Abstract available


  53. GOCH W, Bal W
    Numerical Simulations Reveal Randomness of Cu(II) Induced Abeta Peptide Dimerization under Conditions Present in Glutamatergic Synapses.
    PLoS One. 2017;12:e0170749.
    PubMed     Text format     Abstract available


  54. ARRAZOLA MS, Ramos-Fernandez E, Cisternas P, Ordenes D, et al
    Wnt Signaling Prevents the Abeta Oligomer-Induced Mitochondrial Permeability Transition Pore Opening Preserving Mitochondrial Structure in Hippocampal Neurons.
    PLoS One. 2017;12:e0168840.
    PubMed     Text format     Abstract available


  55. BARTEL F, Vrenken H, Bijma F, Barkhof F, et al
    Regional analysis of volumes and reproducibilities of automatic and manual hippocampal segmentations.
    PLoS One. 2017;12:e0166785.
    PubMed     Text format     Abstract available


  56. SERRANO-POZO A, Sanchez-Garcia MA, Heras-Garvin A, March-Diaz R, et al
    Acute and Chronic Sustained Hypoxia Do Not Substantially Regulate Amyloid-beta Peptide Generation In Vivo.
    PLoS One. 2017;12:e0170345.
    PubMed     Text format     Abstract available


  57. LIANG J, Kulasiri D, Samarasinghe S
    Computational investigation of Amyloid-beta-induced location- and subunit-specific disturbances of NMDAR at hippocampal dendritic spine in Alzheimer's disease.
    PLoS One. 2017;12:e0182743.
    PubMed     Text format     Abstract available


  58. VAN KAMPEN JM, Kay DG
    Progranulin gene delivery reduces plaque burden and synaptic atrophy in a mouse model of Alzheimer's disease.
    PLoS One. 2017;12:e0182896.
    PubMed     Text format     Abstract available


  59. WANG H, Williams D, Griffin J, Saito T, et al
    Time-course global proteome analyses reveal an inverse correlation between Abeta burden and immunoglobulin M levels in the APPNL-F mouse model of Alzheimer disease.
    PLoS One. 2017;12:e0182844.
    PubMed     Text format     Abstract available


  60. CHEN R, Chan PT, Chu H, Lin YC, et al
    Treatment effects between monotherapy of donepezil versus combination with memantine for Alzheimer disease: A meta-analysis.
    PLoS One. 2017;12:e0183586.
    PubMed     Text format     Abstract available


  61. SHI JM, Pei J, Liu EQ, Zhang L, et al
    Bis(sulfosuccinimidyl) suberate (BS3) crosslinking analysis of the behavior of amyloid-beta peptide in solution and in phospholipid membranes.
    PLoS One. 2017;12:e0173871.
    PubMed     Text format     Abstract available


  62. LI T, Xie Y, Bowe B, Xian H, et al
    Serum phosphorus levels and risk of incident dementia.
    PLoS One. 2017;12:e0171377.
    PubMed     Text format     Abstract available


  63. LI T, Li W, Yang Y, Zhang W, et al
    Classification of brain disease in magnetic resonance images using two-stage local feature fusion.
    PLoS One. 2017;12:e0171749.
    PubMed     Text format     Abstract available


  64. PARK HY, Park JW, Song HJ, Sohn HS, et al
    The Association between Polypharmacy and Dementia: A Nested Case-Control Study Based on a 12-Year Longitudinal Cohort Database in South Korea.
    PLoS One. 2017;12:e0169463.
    PubMed     Text format     Abstract available


  65. NICHOLLS SB, DeVos SL, Commins C, Nobuhara C, et al
    Characterization of TauC3 antibody and demonstration of its potential to block tau propagation.
    PLoS One. 2017;12:e0177914.
    PubMed     Text format     Abstract available


  66. JOHANSSON P, Almqvist EG, Wallin A, Johansson JO, et al
    Reduced cerebrospinal fluid concentration of interleukin-12/23 subunit p40 in patients with cognitive impairment.
    PLoS One. 2017;12:e0176760.
    PubMed     Text format     Abstract available


  67. JOE IS, Kim JH, Kim H, Hong JH, et al
    Cyclin Y-mediated transcript profiling reveals several important functional pathways regulated by Cyclin Y in hippocampal neurons.
    PLoS One. 2017;12:e0172547.
    PubMed     Text format     Abstract available


  68. LIU T, Lee M, Ban JJ, Im W, et al
    Cytosolic Extract of Human Adipose Stem Cells Reverses the Amyloid Beta-Induced Mitochondrial Apoptosis via P53/Foxo3a Pathway.
    PLoS One. 2017;12:e0168859.
    PubMed     Text format     Abstract available


  69. LIN HC, Xirasagar S, Lee HC, Huang CC, et al
    Association of Alzhemier's disease with hepatitis C among patients with bipolar disorder.
    PLoS One. 2017;12:e0179312.
    PubMed     Text format     Abstract available


  70. CHUNG MC, Yu TM, Shu KH, Wu MJ, et al
    Hyponatremia and increased risk of dementia: A population-based retrospective cohort study.
    PLoS One. 2017;12:e0178977.
    PubMed     Text format     Abstract available


  71. TUGAEVA KV, Tsvetkov PO, Sluchanko NN
    Bacterial co-expression of human Tau protein with protein kinase A and 14-3-3 for studies of 14-3-3/phospho-Tau interaction.
    PLoS One. 2017;12:e0178933.
    PubMed     Text format     Abstract available


  72. AKHTAR RS, Xie SX, Chen YJ, Rick J, et al
    Regional brain amyloid-beta accumulation associates with domain-specific cognitive performance in Parkinson disease without dementia.
    PLoS One. 2017;12:e0177924.
    PubMed     Text format     Abstract available


  73. SVARD D, Nilsson M, Lampinen B, Latt J, et al
    The effect of white matter hyperintensities on statistical analysis of diffusion tensor imaging in cognitively healthy elderly and prodromal Alzheimer's disease.
    PLoS One. 2017;12:e0185239.
    PubMed     Text format     Abstract available


  74. HAN F, Zhuang TT, Chen JJ, Zhu XL, et al
    Novel derivative of Paeonol, Paeononlsilatie sodium, alleviates behavioral damage and hippocampal dendritic injury in Alzheimer's disease concurrent with cofilin1/phosphorylated-cofilin1 and RAC1/CDC42 alterations in rats.
    PLoS One. 2017;12:e0185102.
    PubMed     Text format     Abstract available


  75. KHAYER N, Marashi SA, Mirzaie M, Goshadrou F, et al
    Three-way interaction model to trace the mechanisms involved in Alzheimer's disease transgenic mice.
    PLoS One. 2017;12:e0184697.
    PubMed     Text format     Abstract available


  76. RAHMAN A, Lamberty Y, Schenker E, Cella M, et al
    Effects of acute administration of donepezil or memantine on sleep-deprivation-induced spatial memory deficit in young and aged non-human primate grey mouse lemurs (Microcebus murinus).
    PLoS One. 2017;12:e0184822.
    PubMed     Text format     Abstract available


  77. SHENG C, Xia M, Yu H, Huang Y, et al
    Abnormal global functional network connectivity and its relationship to medial temporal atrophy in patients with amnestic mild cognitive impairment.
    PLoS One. 2017;12:e0179823.
    PubMed     Text format     Abstract available


  78. DANZIGER SA, Miller LR, Singh K, Whitney GA, et al
    An indicator cell assay for blood-based diagnostics.
    PLoS One. 2017;12:e0178608.
    PubMed     Text format     Abstract available


  79. MABROUK R, Strafella AP, Knezevic D, Ghadery C, et al
    Feasibility study of TSPO quantification with [18F]FEPPA using population-based input function.
    PLoS One. 2017;12:e0177785.
    PubMed     Text format     Abstract available


  80. CHERRY JD, Stein TD, Tripodis Y, Alvarez VE, et al
    CCL11 is increased in the CNS in chronic traumatic encephalopathy but not in Alzheimer's disease.
    PLoS One. 2017;12:e0185541.
    PubMed     Text format     Abstract available


  81. WU YH, Vidal JS, de Rotrou J, Sikkes SAM, et al
    Can a tablet-based cancellation test identify cognitive impairment in older adults?
    PLoS One. 2017;12:e0181809.
    PubMed     Text format     Abstract available


  82. PERSYN E, Karakachoff M, Le Scouarnec S, Le Clezio C, et al
    DoEstRare: A statistical test to identify local enrichments in rare genomic variants associated with disease.
    PLoS One. 2017;12:e0179364.
    PubMed     Text format     Abstract available


  83. YI D, Seo EH, Han JY, Sohn BK, et al
    Development of the Korean Adult Reading Test (KART) to estimate premorbid intelligence in dementia patients.
    PLoS One. 2017;12:e0181523.
    PubMed     Text format     Abstract available


  84. MIKI STEIN A, Munive V, Fernandez AM, Nunez A, et al
    Acute exercise does not modify brain activity and memory performance in APP/PS1 mice.
    PLoS One. 2017;12:e0178247.
    PubMed     Text format     Abstract available


  85. REHKER J, Rodhe J, Nesbitt RR, Boyle EA, et al
    Caspase-8, association with Alzheimer's Disease and functional analysis of rare variants.
    PLoS One. 2017;12:e0185777.
    PubMed     Text format     Abstract available


  86. CHAN YC, Hwang JH
    Effects of Spirulina on the functions and redox status of auditory system in senescence-accelerated prone-8 mice.
    PLoS One. 2017;12:e0178916.
    PubMed     Text format     Abstract available


  87. MOSCONI L, Berti V, Guyara-Quinn C, McHugh P, et al
    Perimenopause and emergence of an Alzheimer's bioenergetic phenotype in brain and periphery.
    PLoS One. 2017;12:e0185926.
    PubMed     Text format     Abstract available


  88. MATONE A, Derlindati E, Marchetti L, Spigoni V, et al
    Identification of an early transcriptomic signature of insulin resistance and related diseases in lymphomonocytes of healthy subjects.
    PLoS One. 2017;12:e0182559.
    PubMed     Text format     Abstract available


  89. MIJALKOV M, Kakaei E, Pereira JB, Westman E, et al
    BRAPH: A graph theory software for the analysis of brain connectivity.
    PLoS One. 2017;12:e0178798.
    PubMed     Text format     Abstract available


  90. PERSSON K, Eldholm RS, Barca ML, Cavallin L, et al
    MRI-assessed atrophy subtypes in Alzheimer's disease and the cognitive reserve hypothesis.
    PLoS One. 2017;12:e0186595.
    PubMed     Text format     Abstract available


  91. ANASTASIOU CA, Yannakoulia M, Kosmidis MH, Dardiotis E, et al
    Mediterranean diet and cognitive health: Initial results from the Hellenic Longitudinal Investigation of Ageing and Diet.
    PLoS One. 2017;12:e0182048.
    PubMed     Text format     Abstract available


    January 2016
  92. KOBAYASHI N, Shinagawa S, Nagata T, Shimada K, et al
    Development of Biomarkers Based on DNA Methylation in the NCAPH2/LMF2 Promoter Region for Diagnosis of Alzheimer's Disease and Amnesic Mild Cognitive Impairment.
    PLoS One. 2016;11:e0146449.
    PubMed     Text format     Abstract available


  93. WEISSOVA K, Bartos A, Sladek M, Novakova M, et al
    Moderate Changes in the Circadian System of Alzheimer's Disease Patients Detected in Their Home Environment.
    PLoS One. 2016;11:e0146200.
    PubMed     Text format     Abstract available


  94. CHANDRASEKARAN S, Bonchev D
    Network Topology Analysis of Post-Mortem Brain Microarrays Identifies More Alzheimer's Related Genes and MicroRNAs and Points to Novel Routes for Fighting with the Disease.
    PLoS One. 2016;11:e0144052.
    PubMed     Text format     Abstract available


  95. STEVENSON JW, Conaty EA, Walsh RB, Poidomani PJ, et al
    The Amyloid Precursor Protein of Alzheimer's Disease Clusters at the Organelle/Microtubule Interface on Organelles that Bind Microtubules in an ATP Dependent Manner.
    PLoS One. 2016;11:e0147808.
    PubMed     Text format     Abstract available


  96. BERLYAND Y, Weintraub D, Xie SX, Mellis IA, et al
    An Alzheimer's Disease-Derived Biomarker Signature Identifies Parkinson's Disease Patients with Dementia.
    PLoS One. 2016;11:e0147319.
    PubMed     Text format     Abstract available


  97. HANE FT, Hayes R, Lee BY, Leonenko Z, et al
    Effect of Copper and Zinc on the Single Molecule Self-Affinity of Alzheimer's Amyloid-beta Peptides.
    PLoS One. 2016;11:e0147488.
    PubMed     Text format     Abstract available


  98. MIZUNO S, Ogishima S, Kitatani K, Kikuchi M, et al
    Network Analysis of a Comprehensive Knowledge Repository Reveals a Dual Role for Ceramide in Alzheimer's Disease.
    PLoS One. 2016;11:e0148431.
    PubMed     Text format     Abstract available


  99. CHANG YT, Huang CW, Chen NC, Lin KJ, et al
    Prefrontal Lobe Brain Reserve Capacity with Resistance to Higher Global Amyloid Load and White Matter Hyperintensity Burden in Mild Stage Alzheimer's Disease.
    PLoS One. 2016;11:e0149056.
    PubMed     Text format     Abstract available


  100. SMITS FM, Porcaro C, Cottone C, Cancelli A, et al
    Electroencephalographic Fractal Dimension in Healthy Ageing and Alzheimer's Disease.
    PLoS One. 2016;11:e0149587.
    PubMed     Text format     Abstract available


  101. KOROLEV IO, Symonds LL, Bozoki AC
    Predicting Progression from Mild Cognitive Impairment to Alzheimer's Dementia Using Clinical, MRI, and Plasma Biomarkers via Probabilistic Pattern Classification.
    PLoS One. 2016;11:e0138866.
    PubMed     Text format     Abstract available


  102. LIN IC, Wang YH, Wang TJ, Wang IJ, et al
    Correction: Glaucoma, Alzheimer's Disease, and Parkinson's Disease: An 8-Year Population-Based Follow-Up Study.
    PLoS One. 2016;11:e0150789.
    PubMed     Text format     Abstract available


  103. KARCH CM, Ezerskiy LA, Bertelsen S, Goate AM, et al
    Alzheimer's Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci.
    PLoS One. 2016;11:e0148717.
    PubMed     Text format     Abstract available


  104. FONSECA MI, Chu S, Pierce AL, Brubaker WD, et al
    Analysis of the Putative Role of CR1 in Alzheimer's Disease: Genetic Association, Expression and Function.
    PLoS One. 2016;11:e0149792.
    PubMed     Text format     Abstract available


  105. PIERSMA D, Fuermaier AB, de Waard D, Davidse RJ, et al
    Prediction of Fitness to Drive in Patients with Alzheimer's Dementia.
    PLoS One. 2016;11:e0149566.
    PubMed     Text format     Abstract available


  106. IDE M, Harris M, Stevens A, Sussams R, et al
    Periodontitis and Cognitive Decline in Alzheimer's Disease.
    PLoS One. 2016;11:e0151081.
    PubMed     Text format     Abstract available



  107. Correction: Network Topology Analysis of Post-Mortem Brain Microarrays Identifies More Alzheimer's Related Genes and MicroRNAs and Points to Novel Routes for Fighting with the Disease.
    PLoS One. 2016;11:e0151122.
    PubMed     Text format     Abstract available


  108. KHOONSARI PE, Haggmark A, Lonnberg M, Mikus M, et al
    Analysis of the Cerebrospinal Fluid Proteome in Alzheimer's Disease.
    PLoS One. 2016;11:e0150672.
    PubMed     Text format     Abstract available


  109. WANG L, Guo L, Lu L, Sun H, et al
    Synaptosomal Mitochondrial Dysfunction in 5xFAD Mouse Model of Alzheimer's Disease.
    PLoS One. 2016;11:e0150441.
    PubMed     Text format     Abstract available


  110. MENG G, Zhong X, Mei H
    A Systematic Investigation into Aging Related Genes in Brain and Their Relationship with Alzheimer's Disease.
    PLoS One. 2016;11:e0150624.
    PubMed     Text format     Abstract available


  111. YIN Y, Liu Y, Pan X, Chen R, et al
    Interleukin-1beta Promoter Polymorphism Enhances the Risk of Sleep Disturbance in Alzheimer's Disease.
    PLoS One. 2016;11:e0149945.
    PubMed     Text format     Abstract available


  112. COVA I, Clerici F, Rossi A, Cucumo V, et al
    Weight Loss Predicts Progression of Mild Cognitive Impairment to Alzheimer's Disease.
    PLoS One. 2016;11:e0151710.
    PubMed     Text format     Abstract available


  113. FRANCOIS A, Julian A, Ragot S, Dugast E, et al
    Correction: Inflammatory Stress on Autophagy in Peripheral Blood Mononuclear Cells from Patients with Alzheimer's Disease during 24 Months of Follow-Up.
    PLoS One. 2016;11:e0143933.
    PubMed     Text format     Abstract available


  114. WANG S, Yu L, Yang H, Li C, et al
    Oridonin Attenuates Synaptic Loss and Cognitive Deficits in an Abeta1-42-Induced Mouse Model of Alzheimer's Disease.
    PLoS One. 2016;11:e0151397.
    PubMed     Text format     Abstract available


  115. SU Y, Blazey TM, Owen CJ, Christensen JJ, et al
    Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study Group.
    PLoS One. 2016;11:e0152082.
    PubMed     Text format     Abstract available


  116. SUNG HY, Choi BO, Jeong JH, Kong KA, et al
    Amyloid Beta-Mediated Hypomethylation of Heme Oxygenase 1 Correlates with Cognitive Impairment in Alzheimer's Disease.
    PLoS One. 2016;11:e0153156.
    PubMed     Text format     Abstract available


  117. PUTHIYEDTH N, Riveros C, Berretta R, Moscato P, et al
    Identification of Differentially Expressed Genes through Integrated Study of Alzheimer's Disease Affected Brain Regions.
    PLoS One. 2016;11:e0152342.
    PubMed     Text format     Abstract available


  118. CHIU PY, Tsai CT, Chen PK, Chen WJ, et al
    Neuropsychiatric Symptoms in Parkinson's Disease Dementia Are More Similar to Alzheimer's Disease than Dementia with Lewy Bodies: A Case-Control Study.
    PLoS One. 2016;11:e0153989.
    PubMed     Text format     Abstract available


  119. WATTS A, Walters RW, Hoffman L, Templin J, et al
    Intra-Individual Variability of Physical Activity in Older Adults With and Without Mild Alzheimer's Disease.
    PLoS One. 2016;11:e0153898.
    PubMed     Text format     Abstract available


  120. SCHMIDT-RICHBERG A, Ledig C, Guerrero R, Molina-Abril H, et al
    Learning Biomarker Models for Progression Estimation of Alzheimer's Disease.
    PLoS One. 2016;11:e0153040.
    PubMed     Text format     Abstract available


  121. CUNHA LP, Lopes LC, Costa-Cunha LV, Costa CF, et al
    Macular Thickness Measurements with Frequency Domain-OCT for Quantification of Retinal Neural Loss and its Correlation with Cognitive Impairment in Alzheimer's Disease.
    PLoS One. 2016;11:e0153830.
    PubMed     Text format     Abstract available


  122. CRISTOFANO A, Sapere N, La Marca G, Angiolillo A, et al
    Serum Levels of Acyl-Carnitines along the Continuum from Normal to Alzheimer's Dementia.
    PLoS One. 2016;11:e0155694.
    PubMed     Text format     Abstract available


  123. PAI MC, Lee CC
    The Incidence and Recurrence of Getting Lost in Community-Dwelling People with Alzheimer's Disease: A Two and a Half-Year Follow-Up.
    PLoS One. 2016;11:e0155480.
    PubMed     Text format     Abstract available


  124. CHEN X, Zhou Y, Wang R, Cao H, et al
    Potential Clinical Value of Multiparametric PET in the Prediction of Alzheimer's Disease Progression.
    PLoS One. 2016;11:e0154406.
    PubMed     Text format     Abstract available


  125. OSTROWSKI PP, Barszczyk A, Forstenpointner J, Zheng W, et al
    Meta-Analysis of Serum Insulin-Like Growth Factor 1 in Alzheimer's Disease.
    PLoS One. 2016;11:e0155733.
    PubMed     Text format     Abstract available


  126. LEE NK, Yang J, Chang EH, Park SE, et al
    Intra-Arterially Delivered Mesenchymal Stem Cells Are Not Detected in the Brain Parenchyma in an Alzheimer's Disease Mouse Model.
    PLoS One. 2016;11:e0155912.
    PubMed     Text format     Abstract available


  127. SASSI C, Ridge PG, Nalls MA, Gibbs R, et al
    Influence of Coding Variability in APP-Abeta Metabolism Genes in Sporadic Alzheimer's Disease.
    PLoS One. 2016;11:e0150079.
    PubMed     Text format     Abstract available


  128. CHEN Y, Liu C, Parker WD, Chen H, et al
    Mitochondrial DNA Rearrangement Spectrum in Brain Tissue of Alzheimer's Disease: Analysis of 13 Cases.
    PLoS One. 2016;11:e0154582.
    PubMed     Text format     Abstract available


  129. KOYAMA A, Hashimoto M, Tanaka H, Fujise N, et al
    Malnutrition in Alzheimer's Disease, Dementia with Lewy Bodies, and Frontotemporal Lobar Degeneration: Comparison Using Serum Albumin, Total Protein, and Hemoglobin Level.
    PLoS One. 2016;11:e0157053.
    PubMed     Text format     Abstract available


  130. KALLO G, Emri M, Varga Z, Ujhelyi B, et al
    Changes in the Chemical Barrier Composition of Tears in Alzheimer's Disease Reveal Potential Tear Diagnostic Biomarkers.
    PLoS One. 2016;11:e0158000.
    PubMed     Text format     Abstract available


  131. LOCKHART SN, Baker SL, Okamura N, Furukawa K, et al
    Dynamic PET Measures of Tau Accumulation in Cognitively Normal Older Adults and Alzheimer's Disease Patients Measured Using [18F] THK-5351.
    PLoS One. 2016;11:e0158460.
    PubMed     Text format     Abstract available


  132. VENTURELLI M, Ce E, Limonta E, Muti E, et al
    Possible Predictors of Involuntary Weight Loss in Patients with Alzheimer's Disease.
    PLoS One. 2016;11:e0157384.
    PubMed     Text format     Abstract available


  133. YUAN H, Xia Q, Ling K, Wang X, et al
    Association of Choline Acetyltransferase Gene Polymorphisms (SNPs rs868750G/A, rs1880676G/A, rs2177369G/A and rs3810950G/A) with Alzheimer's Disease Risk: A Meta-Analysis.
    PLoS One. 2016;11:e0159022.
    PubMed     Text format     Abstract available


  134. YAGI-UTSUMI M, Kato K, Nishimura K
    Membrane-Induced Dichotomous Conformation of Amyloid beta with the Disordered N-Terminal Segment Followed by the Stable C-Terminal beta Structure.
    PLoS One. 2016;11:e0146405.
    PubMed     Text format     Abstract available


  135. LOWE LC, Gaser C, Franke K
    The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
    PLoS One. 2016;11:e0157514.
    PubMed     Text format     Abstract available


  136. CHEN CH, Lin CL, Kao CH
    Irritable Bowel Syndrome Is Associated with an Increased Risk of Dementia: A Nationwide Population-Based Study.
    PLoS One. 2016;11:e0144589.
    PubMed     Text format     Abstract available


  137. HANSEN HH, Fabricius K, Barkholt P, Kongsbak-Wismann P, et al
    Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on beta-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease.
    PLoS One. 2016;11:e0158205.
    PubMed     Text format     Abstract available


  138. LUTSEY PL, Norby FL, Gottesman RF, Mosley T, et al
    Sleep Apnea, Sleep Duration and Brain MRI Markers of Cerebral Vascular Disease and Alzheimer's Disease: The Atherosclerosis Risk in Communities Study (ARIC).
    PLoS One. 2016;11:e0158758.
    PubMed     Text format     Abstract available


  139. GHOSAL K, Fan Q, Dawson HN, Pimplikar SW, et al
    Tau Protein Mediates APP Intracellular Domain (AICD)-Induced Alzheimer's-Like Pathological Features in Mice.
    PLoS One. 2016;11:e0159435.
    PubMed     Text format     Abstract available


  140. SHEKHAR S, Kumar R, Rai N, Kumar V, et al
    Estimation of Tau and Phosphorylated Tau181 in Serum of Alzheimer's Disease and Mild Cognitive Impairment Patients.
    PLoS One. 2016;11:e0159099.
    PubMed     Text format     Abstract available


  141. LI X, Cui J, Yu Y, Li W, et al
    Traditional Chinese Nootropic Medicine Radix Polygalae and Its Active Constituent Onjisaponin B Reduce beta-Amyloid Production and Improve Cognitive Impairments.
    PLoS One. 2016;11:e0151147.
    PubMed     Text format     Abstract available


  142. MAKANI V, Jang YG, Christopher K, Judy W, et al
    BBB-Permeable, Neuroprotective, and Neurotrophic Polysaccharide, Midi-GAGR.
    PLoS One. 2016;11:e0149715.
    PubMed     Text format     Abstract available


  143. HOARAU M, Malbert Y, Irague R, Hureau C, et al
    A Robust and Efficient Production and Purification Procedure of Recombinant Alzheimers Disease Methionine-Modified Amyloid-beta Peptides.
    PLoS One. 2016;11:e0161209.
    PubMed     Text format     Abstract available


  144. LI B, Shi J, Gutman BA, Baxter LC, et al
    Influence of APOE Genotype on Hippocampal Atrophy over Time - An N=1925 Surface-Based ADNI Study.
    PLoS One. 2016;11:e0152901.
    PubMed     Text format     Abstract available


  145. CHOI SH, Park SJ, Kim NR
    Macular Ganglion Cell -Inner Plexiform Layer Thickness Is Associated with Clinical Progression in Mild Cognitive Impairment and Alzheimers Disease.
    PLoS One. 2016;11:e0162202.
    PubMed     Text format     Abstract available


  146. OREMUS M, Xie F, Gaebel K
    Development of Clinical Vignettes to Describe Alzheimer's Disease Health States: A Qualitative Study.
    PLoS One. 2016;11:e0162422.
    PubMed     Text format     Abstract available


  147. LIANG FW, Chan W, Chen PJ, Zimmerman C, et al
    Cognitively-Related Basic Activities of Daily Living Impairment Greatly Increases the Risk of Death in Alzheimers Disease.
    PLoS One. 2016;11:e0160671.
    PubMed     Text format     Abstract available


  148. ROSENTHAL J, Belfort G, Isaacson D
    Early Treatment Critical: Bexarotene Reduces Amyloid-Beta Burden In Silico.
    PLoS One. 2016;11:e0153150.
    PubMed     Text format     Abstract available


  149. RAJA WK, Mungenast AE, Lin YT, Ko T, et al
    Self-Organizing 3D Human Neural Tissue Derived from Induced Pluripotent Stem Cells Recapitulate Alzheimer's Disease Phenotypes.
    PLoS One. 2016;11:e0161969.
    PubMed     Text format     Abstract available


  150. CHEN PT, Chen CL, Lin LT, Lo CH, et al
    Design of Peptide Substrate for Sensitively and Specifically Detecting Two Abeta-Degrading Enzymes: Neprilysin and Angiotensin-Converting Enzyme.
    PLoS One. 2016;11:e0153360.
    PubMed     Text format     Abstract available


  151. SU Y, Blazey TM, Owen CJ, Christensen JJ, et al
    Correction: Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study Group.
    PLoS One. 2016;11:e0163669.
    PubMed     Text format     Abstract available


  152. LEE HK, Velazquez Sanchez C, Chen M, Morin PJ, et al
    Three Dimensional Human Neuro-Spheroid Model of Alzheimer's Disease Based on Differentiated Induced Pluripotent Stem Cells.
    PLoS One. 2016;11:e0163072.
    PubMed     Text format     Abstract available


  153. BAEK MJ, Kim K, Park YH, Kim S, et al
    The Validity and Reliability of the Mini-Mental State Examination-2 for Detecting Mild Cognitive Impairment and Alzheimer's Disease in a Korean Population.
    PLoS One. 2016;11:e0163792.
    PubMed     Text format     Abstract available


  154. CORREA MS, Giacobbo BL, Vedovelli K, Lima DB, et al
    Age Effects on Cognitive and Physiological Parameters in Familial Caregivers of Alzheimer's Disease Patients.
    PLoS One. 2016;11:e0162619.
    PubMed     Text format     Abstract available


  155. SASAOKA S, Matsui T, Hane Y, Abe J, et al
    Time-to-Onset Analysis of Drug-Induced Long QT Syndrome Based on a Spontaneous Reporting System for Adverse Drug Events.
    PLoS One. 2016;11:e0164309.
    PubMed     Text format     Abstract available


  156. MORRONE CD, Thomason LA, Brown ME, Aubert I, et al
    Effects of Neurotrophic Support and Amyloid-Targeted Combined Therapy on Adult Hippocampal Neurogenesis in a Transgenic Model of Alzheimer's Disease.
    PLoS One. 2016;11:e0165393.
    PubMed     Text format     Abstract available


  157. VISHNU VY, Modi M, Sharma S, Mohanty M, et al
    Role of Plasma Clusterin in Alzheimer's Disease-A Pilot Study in a Tertiary Hospital in Northern India.
    PLoS One. 2016;11:e0166369.
    PubMed     Text format     Abstract available


  158. CERMAK S, Kosicek M, Mladenovic-Djordjevic A, Smiljanic K, et al
    Loss of Cathepsin B and L Leads to Lysosomal Dysfunction, NPC-Like Cholesterol Sequestration and Accumulation of the Key Alzheimer's Proteins.
    PLoS One. 2016;11:e0167428.
    PubMed     Text format     Abstract available


  159. DAMMERS C, Yolcu D, Kukuk L, Willbold D, et al
    Selection and Characterization of Tau Binding -Enantiomeric Peptides with Potential for Therapy of Alzheimer Disease.
    PLoS One. 2016;11:e0167432.
    PubMed     Text format     Abstract available


  160. ZHANG M, Schmitt-Ulms G, Sato C, Xi Z, et al
    Drug Repositioning for Alzheimer's Disease Based on Systematic 'omics' Data Mining.
    PLoS One. 2016;11:e0168812.
    PubMed     Text format     Abstract available


  161. KAO LT, Kang JH, Lin HC, Huang CC, et al
    Rheumatoid Arthritis Was Negatively Associated with Alzheimer's Disease: A Population-Based Case-Control Study.
    PLoS One. 2016;11:e0168106.
    PubMed     Text format     Abstract available


  162. STUDNICKI M, Wozniak G, Stepkowski D
    The Calculator of Anti-Alzheimer's Diet. Macronutrients.
    PLoS One. 2016;11:e0168385.
    PubMed     Text format     Abstract available


  163. KOBAYASHI N, Shinagawa S, Nagata T, Shimada K, et al
    Usefulness of DNA Methylation Levels in COASY and SPINT1 Gene Promoter Regions as Biomarkers in Diagnosis of Alzheimer's Disease and Amnestic Mild Cognitive Impairment.
    PLoS One. 2016;11:e0168816.
    PubMed     Text format     Abstract available


  164. PEREZ C, Ziburkus J, Ullah G
    Analyzing and Modeling the Dysfunction of Inhibitory Neurons in Alzheimer's Disease.
    PLoS One. 2016;11:e0168800.
    PubMed     Text format     Abstract available


  165. KRUSE N, Schlossmacher MG, Schulz-Schaeffer WJ, Vanmechelen E, et al
    A First Tetraplex Assay for the Simultaneous Quantification of Total alpha-Synuclein, Tau, beta-Amyloid42 and DJ-1 in Human Cerebrospinal Fluid.
    PLoS One. 2016;11:e0153564.
    PubMed     Text format     Abstract available


  166. LIANG CT, Huang HB, Wang CC, Chen YR, et al
    L17A/F19A Substitutions Augment the alpha-Helicity of beta-Amyloid Peptide Discordant Segment.
    PLoS One. 2016;11:e0154327.
    PubMed     Text format     Abstract available


    January 2015
  167. STEPKOWSKI D, Wozniak G, Studnicki M
    Correlation of Alzheimer's disease death rates with historical per capita personal income in the USA.
    PLoS One. 2015;10:e0126139.
    PubMed     Text format     Abstract available


  168. BHATT DP, Puig KL, Gorr MW, Wold LE, et al
    A pilot study to assess effects of long-term inhalation of airborne particulate matter on early Alzheimer-like changes in the mouse brain.
    PLoS One. 2015;10:e0127102.
    PubMed     Text format     Abstract available


  169. DENK J, Boelmans K, Siegismund C, Lassner D, et al
    MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s Disease.
    PLoS One. 2015;10:e0126423.
    PubMed     Text format     Abstract available


  170. LIU X, Zuo H, Wang D, Peng R, et al
    Improvement of spatial memory disorder and hippocampal damage by exposure to electromagnetic fields in an Alzheimer's disease rat model.
    PLoS One. 2015;10:e0126963.
    PubMed     Text format     Abstract available


  171. VERMA M, Beaulieu-Abdelahad D, Ait-Ghezala G, Li R, et al
    Chronic Anatabine Treatment Reduces Alzheimer's Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD.
    PLoS One. 2015;10:e0128224.
    PubMed     Text format     Abstract available


  172. IRWIN RW, Solinsky CM, Loya CM, Salituro FG, et al
    Allopregnanolone preclinical acute pharmacokinetic and pharmacodynamic studies to predict tolerability and efficacy for Alzheimer's disease.
    PLoS One. 2015;10:e0128313.
    PubMed     Text format     Abstract available


  173. HU C, Cheng L, Sepulcre J, Johnson KA, et al
    A spectral graph regression model for learning brain connectivity of Alzheimer's disease.
    PLoS One. 2015;10:e0128136.
    PubMed     Text format     Abstract available


  174. YUN HJ, Kwak K, Lee JM
    Multimodal Discrimination of Alzheimer's Disease Based on Regional Cortical Atrophy and Hypometabolism.
    PLoS One. 2015;10:e0129250.
    PubMed     Text format     Abstract available


  175. BLANC F, Colloby SJ, Philippi N, de Petigny X, et al
    Cortical Thickness in Dementia with Lewy Bodies and Alzheimer's Disease: A Comparison of Prodromal and Dementia Stages.
    PLoS One. 2015;10:e0127396.
    PubMed     Text format     Abstract available



  176. Correction: Relationship between Adiponectin Gene Polymorphisms and Late-Onset Alzheimer's Disease.
    PLoS One. 2015;10:e0130521.
    PubMed     Text format     Abstract available


  177. JIANG N, Leithold LH, Post J, Ziehm T, et al
    Preclinical Pharmacokinetic Studies of the Tritium Labelled D-Enantiomeric Peptide D3 Developed for the Treatment of Alzheimer s Disease.
    PLoS One. 2015;10:e0128553.
    PubMed     Text format     Abstract available


  178. COLBY-MILLEY J, Cavanagh C, Jego S, Breitner JC, et al
    Sleep-Wake Cycle Dysfunction in the TgCRND8 Mouse Model of Alzheimer's Disease: From Early to Advanced Pathological Stages.
    PLoS One. 2015;10:e0130177.
    PubMed     Text format     Abstract available


  179. ZHANG Y, Lin C, Zhang L, Cui Y, et al
    Cognitive Improvement during Treatment for Mild Alzheimer's Disease with a Chinese Herbal Formula: A Randomized Controlled Trial.
    PLoS One. 2015;10:e0130353.
    PubMed     Text format     Abstract available


  180. ZHAO H, Li X, Wu W, Li Z, et al
    Atrophic Patterns of the Frontal-Subcortical Circuits in Patients with Mild Cognitive Impairment and Alzheimer's Disease.
    PLoS One. 2015;10:e0130017.
    PubMed     Text format     Abstract available


  181. MODI KK, Roy A, Brahmachari S, Rangasamy SB, et al
    Cinnamon and Its Metabolite Sodium Benzoate Attenuate the Activation of p21rac and Protect Memory and Learning in an Animal Model of Alzheimer's Disease.
    PLoS One. 2015;10:e0130398.
    PubMed     Text format     Abstract available



  182. Correction: A Novel Approach to Delayed-Start Analyses for Demonstrating Disease-Modifying Effects in Alzheimer's Disease.
    PLoS One. 2015;10:e0131338.
    PubMed     Text format     Abstract available



  183. Correction: Allopregnanolone Preclinical Acute Pharmacokinetic and Pharmacodynamic Studies to Predict Tolerability and Efficacy for Alzheimer's Disease.
    PLoS One. 2015;10:e0132210.
    PubMed     Text format     Abstract available


  184. BACH JP, Gold M, Mengel D, Hattesohl A, et al
    Measuring Compounds in Exhaled Air to Detect Alzheimer's Disease and Parkinson's Disease.
    PLoS One. 2015;10:e0132227.
    PubMed     Text format     Abstract available


  185. YU H, Wang X, He R, Liang R, et al
    Measuring the Caregiver Burden of Caring for Community-Residing People with Alzheimer's Disease.
    PLoS One. 2015;10:e0132168.
    PubMed     Text format     Abstract available


  186. VERMA M, Beaulieu-Abdelahad D, Ait-Ghezala G, Li R, et al
    Correction: Chronic Anatabine Treatment Reduces Alzheimer's Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD.
    PLoS One. 2015;10:e0134776.
    PubMed     Text format     Abstract available


  187. LUTZENBERGER M, Burwinkel M, Riemer C, Bode V, et al
    Ablation of CCAAT/Enhancer-Binding Protein Delta (C/EBPD): Increased Plaque Burden in a Murine Alzheimer's Disease Model.
    PLoS One. 2015;10:e0134228.
    PubMed     Text format     Abstract available


  188. WENNSTROM M, Surova Y, Hall S, Nilsson C, et al
    The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer's but Not Parkinson's Disease or Dementia with Lewy Bodies.
    PLoS One. 2015;10:e0135458.
    PubMed     Text format     Abstract available


  189. HENDRICKSON RC, Lee AY, Song Q, Liaw A, et al
    High Resolution Discovery Proteomics Reveals Candidate Disease Progression Markers of Alzheimer's Disease in Human Cerebrospinal Fluid.
    PLoS One. 2015;10:e0135365.
    PubMed     Text format     Abstract available


  190. DU LY, Chang LY, Ardiles AO, Tapia-Rojas C, et al
    Alzheimer's Disease-Related Protein Expression in the Retina of Octodon degus.
    PLoS One. 2015;10:e0135499.
    PubMed     Text format     Abstract available


  191. WANG XD, Lu H, Shi Z, Cai L, et al
    A Pilot Study on Clinical and Neuroimaging Characteristics of Chinese Posterior Cortical Atrophy: Comparison with Typical Alzheimer's Disease.
    PLoS One. 2015;10:e0134956.
    PubMed     Text format     Abstract available


  192. KAI K, Hashimoto M, Amano K, Tanaka H, et al
    Relationship between Eating Disturbance and Dementia Severity in Patients with Alzheimer's Disease.
    PLoS One. 2015;10:e0133666.
    PubMed     Text format     Abstract available


  193. COPPOLA G, Di Renzo A, Ziccardi L, Martelli F, et al
    Optical Coherence Tomography in Alzheimer's Disease: A Meta-Analysis.
    PLoS One. 2015;10:e0134750.
    PubMed     Text format     Abstract available


  194. YANG EJ, Ahn S, Ryu J, Choi MS, et al
    Phloroglucinol Attenuates the Cognitive Deficits of the 5XFAD Mouse Model of Alzheimer's Disease.
    PLoS One. 2015;10:e0135686.
    PubMed     Text format     Abstract available


  195. KHAN W, Aguilar C, Kiddle SJ, Doyle O, et al
    A Subset of Cerebrospinal Fluid Proteins from a Multi-Analyte Panel Associated with Brain Atrophy, Disease Classification and Prediction in Alzheimer's Disease.
    PLoS One. 2015;10:e0134368.
    PubMed     Text format     Abstract available


  196. MORI Y, Yoshino Y, Ochi S, Yamazaki K, et al
    TREM2 mRNA Expression in Leukocytes Is Increased in Alzheimer's Disease and Schizophrenia.
    PLoS One. 2015;10:e0136835.
    PubMed     Text format     Abstract available


  197. AMAT-UR-RASOOL H, Ahmed M
    Designing Second Generation Anti-Alzheimer Compounds as Inhibitors of Human Acetylcholinesterase: Computational Screening of Synthetic Molecules and Dietary Phytochemicals.
    PLoS One. 2015;10:e0136509.
    PubMed     Text format     Abstract available


  198. SONG WJ, Son MY, Lee HW, Seo H, et al
    Enhancement of BACE1 Activity by p25/Cdk5-Mediated Phosphorylation in Alzheimer's Disease.
    PLoS One. 2015;10:e0136950.
    PubMed     Text format     Abstract available


  199. ULLAH G, Demuro A, Parker I, Pearson JE, et al
    Analyzing and Modeling the Kinetics of Amyloid Beta Pores Associated with Alzheimer's Disease Pathology.
    PLoS One. 2015;10:e0137357.
    PubMed     Text format     Abstract available


  200. WANG W, Mandel J, Bouaziz J, Commenges D, et al
    A Multi-Marker Genetic Association Test Based on the Rasch Model Applied to Alzheimer's Disease.
    PLoS One. 2015;10:e0138223.
    PubMed     Text format     Abstract available


  201. HSU JL, Lee WJ, Liao YC, Lirng JF, et al
    Posterior Atrophy and Medial Temporal Atrophy Scores Are Associated with Different Symptoms in Patients with Alzheimer's Disease and Mild Cognitive Impairment.
    PLoS One. 2015;10:e0137121.
    PubMed     Text format     Abstract available


  202. CUTLER T, Sarkar A, Moran M, Steffensmeier A, et al
    Drosophila Eye Model to Study Neuroprotective Role of CREB Binding Protein (CBP) in Alzheimer's Disease.
    PLoS One. 2015;10:e0137691.
    PubMed     Text format     Abstract available


  203. BOBKOVA NV, Lyabin DN, Medvinskaya NI, Samokhin AN, et al
    The Y-Box Binding Protein 1 Suppresses Alzheimer's Disease Progression in Two Animal Models.
    PLoS One. 2015;10:e0138867.
    PubMed     Text format     Abstract available


  204. FRANCOIS A, Julian A, Ragot S, Dugast E, et al
    Inflammatory Stress on Autophagy in Peripheral Blood Mononuclear Cells from Patients with Alzheimer's Disease during 24 Months of Follow-Up.
    PLoS One. 2015;10:e0138326.
    PubMed     Text format     Abstract available


  205. LUGLI G, Cohen AM, Bennett DA, Shah RC, et al
    Plasma Exosomal miRNAs in Persons with and without Alzheimer Disease: Altered Expression and Prospects for Biomarkers.
    PLoS One. 2015;10:e0139233.
    PubMed     Text format     Abstract available


  206. KYRTSOS CR, Baras JS
    Modeling the Role of the Glymphatic Pathway and Cerebral Blood Vessel Properties in Alzheimer's Disease Pathogenesis.
    PLoS One. 2015;10:e0139574.
    PubMed     Text format     Abstract available


  207. THAI C, Lim YY, Villemagne VL, Laws SM, et al
    Amyloid-Related Memory Decline in Preclinical Alzheimer's Disease Is Dependent on APOE epsilon4 and Is Detectable over 18-Months.
    PLoS One. 2015;10:e0139082.
    PubMed     Text format     Abstract available


  208. ISHIKI A, Okamura N, Furukawa K, Furumoto S, et al
    Longitudinal Assessment of Tau Pathology in Patients with Alzheimer's Disease Using [18F]THK-5117 Positron Emission Tomography.
    PLoS One. 2015;10:e0140311.
    PubMed     Text format     Abstract available


  209. LIANG H, Shi Y, Kou Z, Peng Y, et al
    Inhibition of BACE1 Activity by a DNA Aptamer in an Alzheimer's Disease Cell Model.
    PLoS One. 2015;10:e0140733.
    PubMed     Text format     Abstract available


  210. HU J, Lin T, Gao Y, Xu J, et al
    The resveratrol trimer miyabenol C inhibits beta-secretase activity and beta-amyloid generation.
    PLoS One. 2015;10:e0115973.
    PubMed     Text format     Abstract available


  211. SIMAN R, Cocca R, Dong Y
    The mTOR Inhibitor Rapamycin Mitigates Perforant Pathway Neurodegeneration and Synapse Loss in a Mouse Model of Early-Stage Alzheimer-Type Tauopathy.
    PLoS One. 2015;10:e0142340.
    PubMed     Text format     Abstract available


  212. SHANMUGANATHAN B, Sheeja Malar D, Sathya S, Pandima Devi K, et al
    Antiaggregation Potential of Padina gymnospora against the Toxic Alzheimer's Beta-Amyloid Peptide 25-35 and Cholinesterase Inhibitory Property of Its Bioactive Compounds.
    PLoS One. 2015;10:e0141708.
    PubMed     Text format     Abstract available


  213. LIU YC, Liu YY, Yip PK, Akanuma K, et al
    More Delusions May Be Observed in Low-Proficient Multilingual Alzheimer's Disease Patients.
    PLoS One. 2015;10:e0140714.
    PubMed     Text format     Abstract available


  214. GUO JP, Pan JX, Xiong L, Xia WF, et al
    Iron Chelation Inhibits Osteoclastic Differentiation In Vitro and in Tg2576 Mouse Model of Alzheimer's Disease.
    PLoS One. 2015;10:e0139395.
    PubMed     Text format     Abstract available


  215. WEISSMILLER AM, Natera-Naranjo O, Reyna SM, Pearn ML, et al
    A gamma-secretase inhibitor, but not a gamma-secretase modulator, induced defects in BDNF axonal trafficking and signaling: evidence for a role for APP.
    PLoS One. 2015;10:e0118379.
    PubMed     Text format     Abstract available


  216. MENDEZ MF, Joshi A, Daianu M, Jimenez E, et al
    White Matter Changes Associated with Resting Sympathetic Tone in Frontotemporal Dementia vs. Alzheimer's Disease.
    PLoS One. 2015;10:e0142445.
    PubMed     Text format     Abstract available


  217. WANG S, Cu Y, Wang C, Xie W, et al
    Protective Effects of Dietary Supplementation with a Combination of Nutrients in a Transgenic Mouse Model of Alzheimer's Disease.
    PLoS One. 2015;10:e0143135.
    PubMed     Text format     Abstract available


  218. NUNES MA, Schowe NM, Monteiro-Silva KC, Baraldi-Tornisielo T, et al
    Chronic Microdose Lithium Treatment Prevented Memory Loss and Neurohistopathological Changes in a Transgenic Mouse Model of Alzheimer's Disease.
    PLoS One. 2015;10:e0142267.
    PubMed     Text format     Abstract available


  219. LARSEN ME, Curry L, Mastellos N, Robb C, et al
    Development of the CHARIOT Research Register for the Prevention of Alzheimer's Dementia and Other Late Onset Neurodegenerative Diseases.
    PLoS One. 2015;10:e0141806.
    PubMed     Text format     Abstract available


  220. MASSO A, Sanchez A, Gimenez-Llort L, Lizcano JM, et al
    Secreted and Transmembrane alphaKlotho Isoforms Have Different Spatio-Temporal Profiles in the Brain during Aging and Alzheimer's Disease Progression.
    PLoS One. 2015;10:e0143623.
    PubMed     Text format     Abstract available


  221. KO SY, Ko HA, Chu KH, Shieh TM, et al
    The Possible Mechanism of Advanced Glycation End Products (AGEs) for Alzheimer's Disease.
    PLoS One. 2015;10:e0143345.
    PubMed     Text format     Abstract available


  222. BARBER RC, Phillips NR, Tilson JL, Huebinger RM, et al
    Can Genetic Analysis of Putative Blood Alzheimer's Disease Biomarkers Lead to Identification of Susceptibility Loci?
    PLoS One. 2015;10:e0142360.
    PubMed     Text format     Abstract available


  223. BYUN MS, Kim SE, Park J, Yi D, et al
    Heterogeneity of Regional Brain Atrophy Patterns Associated with Distinct Progression Rates in Alzheimer's Disease.
    PLoS One. 2015;10:e0142756.
    PubMed     Text format     Abstract available


  224. CAO S, Yu L, Mao J, Wang Q, et al
    Uncovering the Molecular Mechanism of Actions between Pharmaceuticals and Proteins on the AD Network.
    PLoS One. 2015;10:e0144387.
    PubMed     Text format     Abstract available


  225. SAPEY-TRIOMPHE LA, Heckemann RA, Boublay N, Dorey JM, et al
    Neuroanatomical Correlates of Recognizing Face Expressions in Mild Stages of Alzheimer's Disease.
    PLoS One. 2015;10:e0143586.
    PubMed     Text format     Abstract available


  226. ZHONG G, Wang Y, Zhang Y, Guo JJ, et al
    Smoking is associated with an increased risk of dementia: a meta-analysis of prospective cohort studies with investigation of potential effect modifiers.
    PLoS One. 2015;10:e0118333.
    PubMed     Text format     Abstract available


  227. BRENDEL M, Jaworska A, Griessinger E, Rotzer C, et al
    Cross-Sectional Comparison of Small Animal [18F]-Florbetaben Amyloid-PET between Transgenic AD Mouse Models.
    PLoS One. 2015;10:e0116678.
    PubMed     Text format     Abstract available


  228. FUSO A, Ferraguti G, Scarpa S, Ferrer I, et al
    Disclosing bias in bisulfite assay: MethPrimers underestimate high DNA methylation.
    PLoS One. 2015;10:e0118318.
    PubMed     Text format     Abstract available


  229. OKABAYASHI S, Shimozawa N, Yasutomi Y, Yanagisawa K, et al
    Diabetes Mellitus Accelerates Abeta Pathology in Brain Accompanied by Enhanced GAbeta Generation in Nonhuman Primates.
    PLoS One. 2015;10:e0117362.
    PubMed     Text format     Abstract available


  230. WANG X, Blanchard J, Grundke-Iqbal I, Iqbal K, et al
    Memantine Attenuates Alzheimer's Disease-Like Pathology and Cognitive Impairment.
    PLoS One. 2015;10:e0145441.
    PubMed     Text format     Abstract available


  231. DAIANU M, Jacobs RE, Weitz TM, Town TC, et al
    Multi-Shell Hybrid Diffusion Imaging (HYDI) at 7 Tesla in TgF344-AD Transgenic Alzheimer Rats.
    PLoS One. 2015;10:e0145205.
    PubMed     Text format     Abstract available


  232. JIAO B, Liu X, Zhou L, Wang MH, et al
    Polygenic Analysis of Late-Onset Alzheimer's Disease from Mainland China.
    PLoS One. 2015;10:e0144898.
    PubMed     Text format     Abstract available


  233. NUNES MA, Schowe NM, Monteiro-Silva KC, Baraldi-Tornisielo T, et al
    Correction: Chronic Microdose Lithium Treatment Prevented Memory Loss and Neurohistopathological Changes in a Transgenic Mouse Model of Alzheimer's Disease.
    PLoS One. 2015;10:e0145695.
    PubMed     Text format     Abstract available


  234. WANG S, Cui Y, Wang C, Xie W, et al
    Correction: Protective Effects of Dietary Supplementation with a Combination of Nutrients in a Transgenic Mouse Model of Alzheimer's Disease.
    PLoS One. 2015;10:e0146252.
    PubMed     Text format     Abstract available


  235. SU Y, Blazey TM, Snyder AZ, Raichle ME, et al
    Quantitative amyloid imaging using image-derived arterial input function.
    PLoS One. 2015;10:e0122920.
    PubMed     Text format     Abstract available


  236. TOLEA MI, Morris JC, Galvin JE
    Longitudinal associations between physical and cognitive performance among community-dwelling older adults.
    PLoS One. 2015;10:e0122878.
    PubMed     Text format     Abstract available


  237. MAANI R, Yang YH, Kalra S
    Voxel-based texture analysis of the brain.
    PLoS One. 2015;10:e0117759.
    PubMed     Text format     Abstract available


  238. CAI S, Huang L, Zou J, Jing L, et al
    Changes in thalamic connectivity in the early and late stages of amnestic mild cognitive impairment: a resting-state functional magnetic resonance study from ADNI.
    PLoS One. 2015;10:e0115573.
    PubMed     Text format     Abstract available


  239. SANKARANARAYANAN S, Barten DM, Vana L, Devidze N, et al
    Passive immunization with phospho-tau antibodies reduces tau pathology and functional deficits in two distinct mouse tauopathy models.
    PLoS One. 2015;10:e0125614.
    PubMed     Text format     Abstract available


  240. REDOLFI A, Manset D, Barkhof F, Wahlund LO, et al
    Head-to-head comparison of two popular cortical thickness extraction algorithms: a cross-sectional and longitudinal study.
    PLoS One. 2015;10:e0117692.
    PubMed     Text format     Abstract available


  241. YOSHITA M, Arai H, Arai H, Arai T, et al
    Diagnostic accuracy of 123I-meta-iodobenzylguanidine myocardial scintigraphy in dementia with Lewy bodies: a multicenter study.
    PLoS One. 2015;10:e0120540.
    PubMed     Text format     Abstract available


  242. CAMARGO LM, Zhang XD, Loerch P, Caceres RM, et al
    Pathway-based analysis of genome-wide siRNA screens reveals the regulatory landscape of APP processing.
    PLoS One. 2015;10:e0115369.
    PubMed     Text format     Abstract available


  243. DWORZAK J, Renvoise B, Habchi J, Yates EV, et al
    Neuronal Cx3cr1 Deficiency Protects against Amyloid beta-Induced Neurotoxicity.
    PLoS One. 2015;10:e0127730.
    PubMed     Text format     Abstract available


  244. MORIYA M, Miyajima M, Nakajima M, Ogino I, et al
    Impact of cerebrospinal fluid shunting for idiopathic normal pressure hydrocephalus on the amyloid cascade.
    PLoS One. 2015;10:e0119973.
    PubMed     Text format     Abstract available


  245. LYKHMUS O, Voytenko L, Koval L, Mykhalskiy S, et al
    alpha7 Nicotinic acetylcholine receptor-specific antibody induces inflammation and amyloid beta42 accumulation in the mouse brain to impair memory.
    PLoS One. 2015;10:e0122706.
    PubMed     Text format     Abstract available


  246. JUNG CK, Keppler K, Steinbach S, Blazquez-Llorca L, et al
    Fibrillar amyloid plaque formation precedes microglial activation.
    PLoS One. 2015;10:e0119768.
    PubMed     Text format     Abstract available


  247. XUE M, Zhu L, Zhang J, Qiu J, et al
    Low dose nicotine attenuates Abeta neurotoxicity through activation early growth response gene 1 pathway.
    PLoS One. 2015;10:e0120267.
    PubMed     Text format     Abstract available


  248. WU CY, Hu HY, Chow LH, Chou YJ, et al
    The Effects of Anti-Dementia and Nootropic Treatments on the Mortality of Patients with Dementia: A Population-Based Cohort Study in Taiwan.
    PLoS One. 2015;10:e0130993.
    PubMed     Text format     Abstract available


  249. WOLFF M, Unuchek D, Zhang B, Gordeliy V, et al
    Amyloid beta Oligomeric Species Present in the Lag Phase of Amyloid Formation.
    PLoS One. 2015;10:e0127865.
    PubMed     Text format     Abstract available


  250. CHEN J, Li S, Sun W, Li J, et al
    Anti-Diabetes Drug Pioglitazone Ameliorates Synaptic Defects in AD Transgenic Mice by Inhibiting Cyclin-Dependent Kinase5 Activity.
    PLoS One. 2015;10:e0123864.
    PubMed     Text format     Abstract available


  251. SAVONENKO AV, Melnikova T, Wang Y, Ravert H, et al
    Cannabinoid CB2 Receptors in a Mouse Model of Abeta Amyloidosis: Immunohistochemical Analysis and Suitability as a PET Biomarker of Neuroinflammation.
    PLoS One. 2015;10:e0129618.
    PubMed     Text format     Abstract available


  252. CAUGHLIN S, Hepburn JD, Park DH, Jurcic K, et al
    Increased Expression of Simple Ganglioside Species GM2 and GM3 Detected by MALDI Imaging Mass Spectrometry in a Combined Rat Model of Abeta Toxicity and Stroke.
    PLoS One. 2015;10:e0130364.
    PubMed     Text format     Abstract available


    January 2014
  253. GREINER ER, Kelly JW, Palhano FL
    Immunoprecipitation of amyloid fibrils by the use of an antibody that recognizes a generic epitope common to amyloid fibrils.
    PLoS One. 2014;9:e105433.
    PubMed     Text format     Abstract available


  254. JOSE JC, Chatterjee P, Sengupta N
    Cross dimerization of amyloid-beta and alphasynuclein proteins in aqueous environment: a molecular dynamics simulations study.
    PLoS One. 2014;9:e106883.
    PubMed     Text format     Abstract available


  255. SHANG D, Li C, Yao Q, Yang H, et al
    Prioritizing candidate disease metabolites based on global functional relationships between metabolites in the context of metabolic pathways.
    PLoS One. 2014;9:e104934.
    PubMed     Text format     Abstract available


  256. HETTICH MM, Matthes F, Ryan DP, Griesche N, et al
    The Anti-Diabetic Drug Metformin Reduces BACE1 Protein Level by Interfering with the MID1 Complex.
    PLoS One. 2014;9:e102420.
    PubMed     Text format     Abstract available


  257. PETERSON J, Gisslen M, Zetterberg H, Fuchs D, et al
    Cerebrospinal Fluid (CSF) Neuronal Biomarkers across the Spectrum of HIV Infection: Hierarchy of Injury and Detection.
    PLoS One. 2014;9:e116081.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: